More Company News

Nexstim

Technology licencing discussions ended with leading California-based academic institution
16 Jan 2020Read More

Nexstim

Directed share issue of approx €141k to Kreos Capital V (UK) Limited
18 Dec 2019Read More

Nexstim

Health Canada grants Nexstim NBT medical device licence
05 Dec 2019Read More

Nexstim

NBT System installed at Rockford Psychiatric Medical Services, US
02 Dec 2019Read More

Nexstim

Four new NBS system orders in October-November
26 Nov 2019Read More

Nexstim

15,687,350 shares subscribed in the directed share issue raising €1.8m gross
15 Nov 2019Read More

Nexstim

Dr Leena Niemistö starts as new Chair of the Board
11 Nov 2019Read More

Nexstim

Approximately 67.4% of offer warrants under Warrant Plan 2019 used for share subscription
06 Nov 2019Read More

Nexstim

Share subscription period for Warrant Plan 2019 starts on 22 October
21 Oct 2019Read More

Nexstim

Warrant offering secured and additional €1.1m placement
21 Oct 2019Read More

1 2 3 4 … 6
Return to Nexstim
© 2019 Trinity Delta. All rights reserved. Trinity Delta is regulated by the Financial Conduct Authority (Reference number: 725161).